NEWS Quotient Sciences Announces Multimillion-Pound Investment in Drug Substance Manufacturing Facility Read article About us Translational Pharmaceutics Quotient Sciences first brought meaningful innovation to the pharmaceutical industry in 2008 with Translational Pharmaceutics® - a unique delivery platform which shortens development times by more than 12 months. By integrating drug product and clinical testing activities, Translational Pharmaceutics accelerates molecules through development. This saves time and money in reaching key milestones as quickly and efficiently as possible, ensuring better decision making and more streamlined outsourcing. Accelerating molecules from First-in-Human to Proof-of-Concept Selecting and optimizing clinical formulations Accelerating products through to commercial manufacture Translational Pharmaceutics has now been used by pharma and biotech companies on over 400 drug programs. The financial benefits and time savings were quantified in a publication by the Tufts Center for the Study of Drug Development. Get in touch Humanity can’t afford to wait, so neither can we. Let’s talk. About Quotient Sciences Quotient Sciences is a drug development and manufacturing accelerator providing integrated programs and tailored services across the entire development pathway. Cutting through silos across a range of drug development capabilities, we save precious time and money in getting drugs to patients. Everything we do for our customers is driven by an unswerving belief that ideas need to become solutions, molecules need to become cures, fast. Because humanity needs solutions, fast. Follow us LinkedIn Twitter Facebook Contact us Quotient Sciences UK +44 (0)115 974 9000 US +1 800 769 3518 Get in touch Copyright © Quotient Sciences 2021 Policies, Statements and Terms of Use Suppliers We use cookies to help us to improve our site and enables us to the best possible service and customer experience. By clicking accept you are agreeing to let us share your data with select third parties for analytics and marketing purposes. Decline Accept